Literature DB >> 19549758

Hepcidin decreases iron transporter expression in vivo in mouse duodenum and spleen and in vitro in THP-1 macrophages and intestinal Caco-2 cells.

Bomee Chung1, Timothy Chaston, Joanne Marks, Surjit Kaila Srai, Paul A Sharp.   

Abstract

Hepcidin is thought to control iron metabolism by interacting with the iron efflux transporter ferroportin. In macrophages, there is compelling evidence that hepcidin directly regulates ferroportin protein expression. However, the effects of hepcidin on intestinal ferroportin levels are less conclusive. In this study, we compared the effects of hepcidin on iron transporter expression in the spleen and duodenum of mice treated with hepcidin over a 24- to 72-h period and observed a marked decrease in the expression of ferroportin in both duodenal enterocytes and splenic macrophages following treatment. Changes in transporter protein expression were associated with significant decreases in duodenal iron transport and serum iron. In THP-1 macrophages, ferroportin protein levels were decreased by 300 and 1000 nmol/L hepcidin. In contrast, ferroportin protein expression was unaltered in intestinal Caco-2 cells following exposure to hepcidin. However, iron efflux from Caco-2 cells was significantly inhibited in the presence of hepcidin, suggesting that the peptide could block ferroportin function in these cells. We conclude that hepcidin regulates the release of iron from both enterocytes and macrophages. However, taken together with our previous work, it is apparent that macrophages are more sensitive than enterocytes to a hepcidin challenge.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19549758     DOI: 10.3945/jn.108.102905

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  29 in total

1.  Hypoxia inhibits hepcidin expression in HuH7 hepatoma cells via decreased SMAD4 signaling.

Authors:  Timothy B Chaston; Pavle Matak; Katayoun Pourvali; Surjit K Srai; Andrew T McKie; Paul A Sharp
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-02       Impact factor: 4.249

Review 2.  Genetic variation in hepcidin expression and its implications for phenotypic differences in iron metabolism.

Authors:  Henry K Bayele; Surjit Kaila S Srai
Journal:  Haematologica       Date:  2009-09       Impact factor: 9.941

Review 3.  Ferroportin-mediated iron transport: expression and regulation.

Authors:  Diane M Ward; Jerry Kaplan
Journal:  Biochim Biophys Acta       Date:  2012-03-13

4.  Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin.

Authors:  Sharraya Aschemeyer; Bo Qiao; Deborah Stefanova; Erika V Valore; Albert C Sek; T Alex Ruwe; Kyle R Vieth; Grace Jung; Carla Casu; Stefano Rivella; Mika Jormakka; Bryan Mackenzie; Tomas Ganz; Elizabeta Nemeth
Journal:  Blood       Date:  2017-12-13       Impact factor: 22.113

5.  How does hepcidin hinder ferroportin activity?

Authors:  De-Liang Zhang; Tracey A Rouault
Journal:  Blood       Date:  2018-02-22       Impact factor: 22.113

6.  Duodenal absorption and tissue utilization of dietary heme and nonheme iron differ in rats.

Authors:  Chang Cao; Carrie E Thomas; Karl L Insogna; Kimberly O O'Brien
Journal:  J Nutr       Date:  2014-09-10       Impact factor: 4.798

7.  Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis.

Authors:  Emilio Ramos; Piotr Ruchala; Julia B Goodnough; Léon Kautz; Gloria C Preza; Elizabeta Nemeth; Tomas Ganz
Journal:  Blood       Date:  2012-09-18       Impact factor: 22.113

8.  Effects of elevated dietary iron on the gastrointestinal expression of Nramp genes and iron homeostasis in rainbow trout (Oncorhynchus mykiss).

Authors:  Raymond W M Kwong; Charmain D Hamilton; Som Niyogi
Journal:  Fish Physiol Biochem       Date:  2012-08-15       Impact factor: 2.794

Review 9.  Regulation of tissue iron homeostasis: the macrophage "ferrostat".

Authors:  Nathan C Winn; Katrina M Volk; Alyssa H Hasty
Journal:  JCI Insight       Date:  2020-01-30

10.  Iron refractory iron deficiency anemia: presentation with hyperferritinemia and response to oral iron therapy.

Authors:  Dong-Anh Khuong-Quang; Jeremy Schwartzentruber; Mark Westerman; Pierre Lepage; Karin E Finberg; Jacek Majewski; Nada Jabado
Journal:  Pediatrics       Date:  2013-01-14       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.